In This Article:
-
Universal Health Services Inc (NYSE: UHS) reported Q2 revenue of $3.32 billion, +3.9% Y/Y, slightly above the consensus of $3.28 billion.
-
The company reported an adjusted EPS of $2.20, down from $3.76 a year ago and missing the consensus of $2.35, but higher than the management guidance of $2.05 - $2.15.
-
Acute care hospitals owned adjusted admissions decreased by 0.7%, and adjusted patient days increased by 1.8% Y/Y.
-
Net revenues generated from acute care services on the same facility basis increased by 3.3%.
-
In behavioral health care facilities on a same facility basis, adjusted admissions decreased by 0.1%, and adjusted patient days increased 0.7%.
-
Adjusted EBITDA reached $382.56 million, and the margin declined from 17.9% to 11.5%.
-
Universal Health Services continues to experience a shortage of nurses, other clinical staff, and support personnel at acute care and behavioral health care hospitals.
-
The company revised guidance assuming that staffing vacancies and the corresponding premium pay expenditures will continue declining in the year's second half.
-
It anticipates that non-COVID patient volumes will incrementally improve, although both at a slower pace than the original forecast.
-
Price Action: UHS shares closed 4.61% lower at $104.84 during the post-market session on Monday.
See more from Benzinga
Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.